Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Centre Hospitalier Universitaire De Rouen has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio's current activity is limited to 1 distinct examiner and 1 distinct art unit, which reflects a focused prosecution stage. Having this specific pending action count indicates that the organization's current patent office interactions are concentrated on a specific matter. This lack of volume across different examiners means the organization's immediate results depend on a limited point of review.
ALAM, DANYAL HASSAN is identified as the busiest examiner for this entity. This examiner is currently handling 1 pending office action, matching the total count of pending actions for the organization. Because the workload is confined to this examiner and 1 distinct art unit, the prosecution strategy must be specialized to the preferences of this specific individual. The involvement of the assigned art unit suggests the pending application falls within a specific technical niche, requiring the organization to adhere to the particular examination guidelines of that division.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, DANYAL HASSAN | 1 | 66.7% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996294 | METHODS FOR DETECTING THE PRESENCE OF CORONAVIRUS-SPECIFIC ANTIBODIES IN A SUBJECT | ALAM, DANYAL HASSAN | — |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17996294 | METHODS FOR DETECTING THE PRESENCE OF CORONAVIRUS-SPECIFIC ANTIBODIES IN A SUBJECT | ALAM, DANYAL HASSAN | 1600 | §101§103§112 | Final Rejection | — | Pending | Oct 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Hospitalier Universitaire De Rouen has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Danyal Hassan Alam has the most, with 1 of Centre Hospitalier Universitaire De Rouen's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
